Vortioxetine for depression: the evidence for its current use in the UK: COMMENTARY ON… COCHRANE CORNER
De Giorgi, Riccardo
MetadataShow full item record
Riccardo de Giorgi. Vortioxetine for depression: the evidence for its current use in the UK: COMMENTARY ON… COCHRANE CORNER. BJPsych Advances Vol 25. 1 2019 p3-6.
The pharmacological treatment of depression is often hampered by side-effects and unsatisfactory response to treatment. Vortioxetine is one of the newest antidepressants on the market, purportedly with a different mechanism of action compared with other antidepressants. This month's Cochrane Corner review examines the evidence available for the use of vortioxetine as a first-line treatment for depression in adults. This commentary puts the Cochrane review's findings into their clinical context and revises them in view of earlier and later studies
Published online: https://doi.org/10.1192/bja.2018.62 Eligible users can access the full text via NHS OpenAthens at [https://www.cambridge.org/core/journals/bjpsych-advances/article/vortioxetine-for-depression-the-evidence-for-its-current-use-in-the-uk/D716323C054B238F4E44B4AAF6467D75] (login required).